Trial Profile
Single Arm Clinical Study of Human Amniotic Epithelial Cells in Preventing Acute Graft-versus-host Disease After Hematopoietic Stem Cell Transplantation
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 12 Dec 2018
At a glance
- Drugs Human amniotic epithelial cells-Shanghai-iCELL-Biotechnology (Primary)
- Indications Graft-versus-host disease
- Focus Adverse reactions
- 12 Dec 2018 New trial record